Back to search
Early Stage Prostate Cancer
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Early Stage Prostate Cancer trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Early Stage Prostate Cancer trials you may qualify forThis study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing s…
LEAH is a prospective, observational, single-centre, non-randomised, open-label study of people at increased risk of cancer or malignant disease. The main obje…
This clinical trial is an adaptive study of a novel vimentin inhibitor in cancers. It is an open label, multicentre, single ascending dose level in phase I and…
This Phase II, single arm study evaluates a PSA-response-adapted approach to salvage radiotherapy after radical prostatectomy for prostate cancer. All participa…
This study will use polysomnography, alongside other methodologies such as questionnaires, actigraphic measurements and salivary melatonin samples used in previ…
This is a retrospective monoinstitutional study which analyses the results of advanced radiotherapy (IGRT, IMRT, SBRT, and PET-guided) performed for radical, ad…
The purpose of this study is to collect information on how patients and their partners/close allies make treatment decisions when they have been diagnosed with…
This phase III trial compares the effect of adding darolutamide to ADT versus ADT alone after surgery for the treatment of high-risk prostate cancer. ADT reduce…